Phillip Lin

Phillip Lin

Auto-generated profile, based on publicly available information

Phillip Lin

Division of Genetic Medicine, Department of Medicine (P.L., M.B., N.K., B.L.A.P., J.M.L., J.B., E.R.G.), Vanderbilt University Medical Center, Nashville, TN

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2023 in Nature Machine Intelligence
Verified
Journal Article
Open access
PDF file
RVRamon Viñas
Ramon Viñas
CJChaitanya K. Joshi
Chaitanya K. Joshi
DGDobrik Georgiev
Dobrik Georgiev
PLPhillip Lin
Phillip Lin
BDBianca Dumitrascu
Bianca Dumitrascu
PLPietro Lio
Pietro Lio
Integrating gene expression across tissues and cell types is crucial for understanding the coordinated biological mechanisms that drive disease and characterize homoeostasis. However, traditional multi-tissue integration methods either cannot handle uncollected tissues or rely on genotype information, which is often unavailable and subject to privacy concerns. Here we present HYFA (hypergraph factorization), a parameter-efficient graph representation learning approach for joint imputation of multi-tissue and cell-type gene expression. HYFA is genotype agnostic, supports a variable number of collected tissues per individual, and imposes strong inductive biases to leverage the shared regulatory architecture of tissues and genes. In performance comparison on Genotype–Tissue Expression project data, HYFA achieves superior performance over existing methods, especially when multiple reference tissues are available. The HYFA-imputed dataset can be used to identify replicable regulatory genetic variations (expression quantitative trait loci), with substantial gains over the original incomplete dataset. HYFA can accelerate the effective and scalable integration of tissue and cell-type transcriptome biorepositories.

5 May 2026 in Circulation
Verified
Journal Article
Open access
ILIsabela Landsteiner
Isabela Landsteiner
LSLindsey K. Stolze
Lindsey K. Stolze
TPTess E. Peterson
Tess E. Peterson
APAndrew Perry
Andrew Perry
PLPhillip Lin
Phillip Lin
GLGregory D. Lewis
Gregory D. Lewis
BACKGROUND: Exercise unmasks limitations in multiorgan system reserve capacity characteristic of heart failure with preserved ejection fraction (HFpEF). However, the metabolic and genetic underpinnings of exercise deficits and their cumulative contribution to HFpEF severity and prognosis remain incompletely understood. METHODS: We used invasive cardiopulmonary exercise testing, metabolite profiling, and genomics to simultaneously characterize 7 exercise physiological deficits in patients with HFpEF: reduced exercise stroke volume and heart rate, steep pulmonary capillary wedge pressure/cardiac output slope, elevated pulmonary vascular resistance, pulmonary mechanical limitation to exercise, impaired peripheral oxygen extraction, and obesity-related exaggerated metabolic cost of initiating exercise. We first mapped the distribution, functional, and prognostic significance of these exercise deficits. We then applied least absolute shrinkage and selection operator regression to identify metabolite signatures of each exercise deficit and measured the relation of these signatures with clinical-demographic features, cardiac magnetic resonance imaging, and incident heart failure in 6345 individuals in the MESA study (Multi-Ethnic Study of Atherosclerosis) with ≈20 years of follow-up. Last, we mapped deficit-implicated metabolites to tissue-specific genetic variation in ≈2 million individuals, including ≈153 000 with heart failure, leveraging the largest genome-wide association studies of HFpEF comorbidities (obesity, renal disease, diabetes) to evaluate shared metabolic mechanisms of HFpEF pathophysiology. RESULTS: Our invasive cardiopulmonary exercise testing HFpEF cohort (age, 61.7±14.1 years; 54% female; body mass index, 30.6±6.7 kg/m 2 ) exhibited a broad range of compound cardiac and extracardiac exercise deficits. Individuals with ≥5 exercise deficits had a nearly 4-fold higher hazard of incident cardiovascular event or mortality (hazard ratio, 3.90 [95% CI, 1.74–8.75]; P <0.0001). The metabolite signature of exercise pulmonary capillary wedge pressure/cardiac output slope conferred a hazard ratio of 1.43 per 1-SD increment (95% CI, 1.20–1.71; P <0.001) for incident heart failure in MESA. Addition of all invasive cardiopulmonary exercise testing deficit metabolic signatures in a single model yielded ≈20% continuous net reclassification improvement over traditional HFpEF risk factors. Genes implicated by the exercise deficit metabolome were enriched in the heart failure genome-wide association study (≈2 million) and shared with obesity, renal dysfunction, and diabetes, highlighting a lifelong shared predisposition to heart failure (including HFpEF) and its comorbidities. CONCLUSIONS: Organ-specific responses to exercise and their circulating metabolite signatures are strongly linked to HFpEF development and prognosis. These results offer a paradigm for parsing HFpEF subphenotypes and prioritizing metabolic mechanisms of HFpEF.

1 June 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
BEBassim El-Sabawi
Bassim El-Sabawi
XHXiaoning Huang
Xiaoning Huang
PLPhillip Lin
Phillip Lin
MAMohammad Yaser Anwar
Mohammad Yaser Anwar
MBMichael Betti
Michael Betti
RSRavi V. Shah
Ravi V. Shah
BACKGROUND: Joint use of multiple molecular layers can be useful to prioritize targets for mechanistic studies. Application of this approach to coronary disease in large populations is an emerging field. METHODS: We used reported circulating proteomic data (Somascan aptamer-based) from ≈3000 individuals in the CARDIA study (Coronary Artery Risk Development in Young Adults), measuring association with prevalent and 10-year incident coronary artery calcium (CAC) score. We used a multiparametric approach to prioritize circulating protein-CAC associations via genomics of circulating protein levels and coronary artery transcription. RESULTS: Proteins linked to prevalent/incident CAC in CARDIA implicated pathogenic mechanisms of vascular disease, including fibrosis and inflammation (GDF-15 [growth/differentiation factor 15], CDCP1 [CUB domain–containing protein 1], GSN [gelsolin], THBS2 [thrombospondin-2], chemokines, RNAS6 [ribonuclease K6]), oxidative lipid metabolism (CILP2; cartilage intermediate layer protein 2), extracellular matrix remodeling and signaling (MMPs [matrix metalloproteinases], TIMP-1 [tissue inhibitor of metalloproteinases 1], integrins), calcification (Notch 1, ARHGAP36 [Rho GTPase-activating protein 36]), and metabolism (GIP [gastric inhibitory polypeptide]), as well as new proteins not previously reported. Using proteome-wide association study genetic approaches, several targets with nominal evidence in CAC proteomics were associated with atherosclerosis or myocardial infarction in over 300K individuals, including PCSK9 (proprotein convertase subtilisin/kexin type 9) and APOC1. Finally, the coronary artery–specific transcriptome-wide association study of CAC yielded genes with previously implicated mechanistic roles in vascular homeostasis, inflammation, and metabolism, as well as genes without previously described function in CAC. Overlap across CAC proteomics and transcriptome-wide association study highlighted genes involved in vascular inflammation (S100A9), cardiac development (HES1 [transcription factor HES-1]), vessel wall structure (SPARCL1 [SPARC-like protein 1]), and vascular dysfunction or plaque (NOTCH3 [neurogenic locus notch homolog protein 3], TNFSF12 [tumor necrosis factor ligand superfamily member 12], S100A12 [protein S100-A12]). CONCLUSIONS: These results report population-level multiomics in human coronary calcification, presenting a method to identify disease-relevant targets through integration of human genetic approaches with multiomics.